
Sanoculis
About
MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients’ through simplicity, low cost, fewer post-surgical complications and less hospitalization. • A novel Glaucoma treatment • Leaves nothing behind (stent-less) thus lowering the risk of complications • Can be easily combined with Cataract surgery • Medication-sparing which improves patients' quality of life
Technology stack
detected 2026-06-16Est. monthly stack spend~$140/mo
CDN
Cloudflare
Email
Google Workspace
Stack
jQuery
Shopify
A11y
UserWay
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Sanoculis do?
MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients’ through simplicity, low cost, fewer post-surgical complications and less hospitalization. • A novel Glaucoma treatment • Leaves nothing behind (stent-less) thus lowering the risk of complications • Can be easily combined with Cataract surgery • Medication-sparing w…
When was Sanoculis founded?
Sanoculis was founded in 2012.
What industry does Sanoculis operate in?
Sanoculis operates in Healthcare.
How many employees does Sanoculis have?
Sanoculis has approximately 10 people on record.
